These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6969004)

  • 1. [Stage Ic cancer of the cervix. A clinical and immunological analysis (author's transl)].
    Tulzer H; Kupka S; Wagner G
    Wien Klin Wochenschr; 1980 Aug; 92(16):569-73. PubMed ID: 6969004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic factors of stage IB and IIA carcinoma of the cervix treated by surgery].
    Zhang WH; Wu LY; Bai P; Li SM; Zhang R; Li B; Sun JH; Wu AR
    Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):490-2. PubMed ID: 15555341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis, classification and prognosis of cancer of the uterine cervix].
    Dargent D
    Rev Prat; 1990 Jan; 40(1):19-25. PubMed ID: 2405470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic factors in gynecologic cancer].
    Yajima A; Sato S
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2209-15. PubMed ID: 3408255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors in surgically treated stage ib-iib cervical carcinomas with special emphasis on the importance of tumor volume.
    Trattner M; Graf AH; Lax S; Forstner R; Dandachi N; Haas J; Pickel H; Reich O; Staudach A; Winter R
    Gynecol Oncol; 2001 Jul; 82(1):11-6. PubMed ID: 11426955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
    Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC
    Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Risk factors and prognosis of node-positive cervical carcinoma].
    Feng SY; Zhang YN; Liu JG
    Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic factors in uterine cervical and corpus cancer].
    Yoshioka T; Inoue Y; Hoshiai H; Noda K
    Gan To Kagaku Ryoho; 1995 Sep; 22(10):1417-22. PubMed ID: 7668881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The prognostic significance of stromal reaction and other histopathological parameters after Wertheim radical hysterectomy (author's transl)].
    Riss P; Szalay S; Bartl W; Breitenecker G
    Wien Klin Wochenschr; 1981 May; 93(11):351-4. PubMed ID: 7269614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic factors affecting the results of surgical treatment of cervical cancer].
    Lou H; Chen Y; Sun H
    Zhonghua Zhong Liu Za Zhi; 1996 Jan; 18(1):64-6. PubMed ID: 8732118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
    Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
    Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stromal invasion of the cervix can be excluded from the criteria for using adjuvant radiotherapy following radical surgery for patients with cervical cancer.
    Shimada M; Kigawa J; Takahashi M; Minagawa Y; Okada M; Kanamori Y; Itamochi H; Oishi T; Iba T; Terakawa N
    Gynecol Oncol; 2004 Jun; 93(3):628-31. PubMed ID: 15196855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors that affect survival after the treatment of early stage cervical carcinoma.
    Atasii T; Aksu MF; Cetinkaya MB
    Int Surg; 2000; 85(2):147-51. PubMed ID: 11071333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective malignancy grading, flow cytometry DNA-measurements and adjuvant chemotherapy for invasive squamous cell carcinoma of the uterine cervix.
    Willén R; Himmelmann A; Långström-Einarsson E; Fernö M; Ranstam J; Baldetorp B; Skjaerris J; Prien-Larsen J; Tropé C; Stendahl U
    Anticancer Res; 1993; 13(4):1187-96. PubMed ID: 8352543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early stage cervical cancer: adjuvant treatment in negative lymph node cases.
    Sartori E; Tisi G; Chiudinelli F; La Face B; Franzini R; Pecorelli S
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S170-4. PubMed ID: 17765298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor size is of prognostic value in surgically treated FIGO stage II cervical cancer.
    Horn LC; Fischer U; Raptis G; Bilek K; Hentschel B
    Gynecol Oncol; 2007 Nov; 107(2):310-5. PubMed ID: 17826822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in patients with with locally advanced cervical cancer treated with radical hysterectomy and adjuvant radiotherapy.
    Frigerio L; Mariani A; Gandini L; Origoni M; Galli L; Rabaiotti E; Aletti G; Ferrari A
    Int Surg; 1998; 83(3):265-70. PubMed ID: 9870789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Incidence of postoperative recurrence (stages Ia-IIb) of squamous cell carcinoma of uterine cervix in correlation with cellular grading (author's transl)].
    Elling D; Bartel U
    Zentralbl Gynakol; 1982; 104(8):474-81. PubMed ID: 7113515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors and clinicopathologic characteristics of invasive adenocarcinoma of the uterine cervix.
    Chargui R; Damak T; Khomsi F; Ben Hassouna J; Chaieb W; Hechiche M; Gamoudi A; Boussen H; Benna F; Rahal K
    Am J Obstet Gynecol; 2006 Jan; 194(1):43-8. PubMed ID: 16389008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated full-thickness cervical stromal invasion warrants post-hysterectomy pelvic radiotherapy in FIGO stages IB-IIA uterine cervical carcinoma.
    Moon SH; Wu HG; Ha SW; Lee HP; Kang SB; Song YS; Park NH; Kim JW; Park IA; Kim BH
    Gynecol Oncol; 2007 Jan; 104(1):152-7. PubMed ID: 16935323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.